Last Updated on August 31, 2024 by The Health Master
Bulk Drug
The Indian government has decided to give bulk drug parks an extra year to complete their development.
The Scheme for Promotion of Bulk Drug Parks, introduced to bolster domestic drug manufacturing, has seen a mixed bag of results across different states.
Financial Allocation and Utilization
The Centre has generously invested Rs. 1,000 crore each in Andhra Pradesh, Gujarat, and Himachal Pradesh to establish common infrastructure facilities (CIFs) essential for bulk drug manufacturing.
While Gujarat and Himachal Pradesh have made significant progress in utilizing the first installment of funds, Andhra Pradesh lags behind.
- Gujarat: Utilized Rs. 129.17 crore.
- Himachal Pradesh: Utilized Rs. 21.37 crore.
- Andhra Pradesh: No fund utilization recorded.
Andhra Pradesh’s Bulk Drug Park Faces Delays
Initially planned for Kakinada, Andhra Pradesh’s bulk drug park is now being developed in Nakkapalli.
The state government is currently focusing on external infrastructure, including road construction and land acquisition.
Challenges and Opportunities
The extension of the scheme highlights the challenges faced in setting up these large-scale projects.
However, it also presents an opportunity to refine the process and ensure optimal utilization of funds.
Potential for Boosting Pharmaceutical Industry
Once fully operational, these bulk drug parks have the potential to revolutionize India’s pharmaceutical industry.
By reducing manufacturing costs and enhancing competitiveness, they can contribute significantly to the country’s economic growth.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Exploring Himachal Pradesh’s New Bulk Drug Park
Govt’s 1,000 Cr Budget for Pharma and Medical Device Parks
Bangladesh API Park offers for Indian API industry
Pharma Revolution: UP’s Grand Plan for Lalitpur’s Pharma Park
ICMR Announces Initiative for Evidence-Based Antibiotic Use Guidelines
Revised Schedule M: Discussion on Quality Risk Management
USFDA approval granted for blockbuster drug for Cancer treatment
Drug recall: B. Braun recalls Saline Solution due to this reason
USFDA issues warning letter to Eugia Pharma subsidiary of Aurobindo
Govt Job: For the post of Director at (RDTL) Regional Drugs Testing Laboratory
Govt ban on Pain relief combination S(+)Etodolac & Paracetamol
Phase 3 Clinical Trial for Indigenous Dengue Vaccine Begins in India
NPPA revised Ceiling price of 4 scheduled formulation: August 2024
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
